Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Neuroblastoma × capmatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Other hematologic neoplasm 1 Gastrointestinal 1 CNS 1

Conditions

Neoplasms by Site 2 Neoplasms by Histologic Type 2 Neoplasms 2 Hematologic Neoplasms 2 Stomach Neoplasms 1 Sarcoma 1 Neuroblastoma 1 Lymphoproliferative Disorders 1 Glioma 1

Interventions

omburtamab I-131 1 capmatinib 1 alectinib 1 Melphalan 1 Etoposide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06988475 2025-11-24

DETERMINE

Cancer Research UK

Phase 2/3 Recruiting

CNSGastrointestinalOther hematologic neoplasmSarcoma

Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neuroblastoma, Sarcoma, Stomach Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡